Page 314 - AIDSBK23C
P. 314

Page 314




               203     Lester RT, Yao XD, Ball TB, McKinnon LR, Kaul R, Wachihi C, Jaoko W, et al. Toll-
                       like receptor expression and responsiveness are increased in viraemic HIV-1 infection.
                       AIDS. 2008;22:685-694.

               204     Ribeiro RM. Dynamics of CD4+ T cells in HIV-1 infection. Immunol Cell Biol.
                       2007;85:287-294.

               205     Van der Kuyl AC, Cornelissen M. Identifying HIV-1 dual infections. Retrovirology.
                       2007;4:67.

               206     Waters L, Smit E. HIV-1 superinfection. Curr Opin Infect Dis. 2012;25(1):42-50.

               207     Phillips AN, Elford J, Sabin C, Bofill M, Janossy G, Lee CA. Immunodeficiency and the
                       risk of death in HIV infection. JAMA. 1992;268:2662-2666.

               208     Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H; Centers for Disease
                       Control and Prevention. Guidelines for prevention and treatment of opportunistic
                       infections in HIV-infected adults and adolescents: recommendations from CDC, the
                       National Institutes of Health, and the HIV Medicine Association of the Infectious
                       Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1-207.

               209     Tsoukas CM, Bernard NF. Markers predicting progression of human immunodeficiency
                       virus-related disease. Clin Microbiol Rev. 1994;7:14-28.

               210     Centers for Disease Control. Report of the NIH Panel to define principles of therapy of
                       HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults
                       and adolescents. MMWR. 1998;47(RR-5):1-83.

               211     Roberts L, Passmore JA, Mlisana K, Williamson C, Little F, Bebell LM, Walzl G, et al.
                       Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load
                       set point in women. J Infect Dis. 2012;205(2):194-203.

               212     Chaisson RE, Gallant JE, Keruly JC, Moore RD. Impact of opportunistic disease on
                       survival in patients with HIV infection. AIDS. 1998;12:29-33.

               213     Singh KK, Spector SA. Host genetic determinants of human immunodeficiency virus
                       infection and disease progression in children. Pediatr Res. 2009;65(5 Pt 2):55R-63R.

               214     Brettle RP, Leen CLS. The natural history of HIV and AIDS in women. AIDS.
                       1991;5:1283-1292.

               215     Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human
                       immunodeficiency virus disease. N Engl J Med. 1995;333:751-756.
   309   310   311   312   313   314   315   316   317   318   319